Cosmo Bio Company,Limited (3386.T)

JPY 1130.0

(0.0%)

Revenue Summary of Cosmo Bio Company,Limited

  • Cosmo Bio Company,Limited's latest annual revenue in 2023 was 9.34 Billion JPY , down -2.23% from previous year.
  • Cosmo Bio Company,Limited's latest quarterly revenue in 2024 Q2 was 2.18 Billion JPY , down -25.72% from previous quarter.
  • Cosmo Bio Company,Limited reported a annual revenue of 9.55 Billion JPY in annual revenue 2022, up 3.49% from previous year.
  • Cosmo Bio Company,Limited reported a annual revenue of 9.23 Billion JPY in annual revenue 2021, up 14.08% from previous year.
  • Cosmo Bio Company,Limited reported a quarterly revenue of 2.18 Billion JPY for 2024 Q2, down -25.72% from previous quarter.
  • Cosmo Bio Company,Limited reported a quarterly revenue of 2.82 Billion JPY for 2023 Q1, up 16.57% from previous quarter.

Annual Revenue Chart of Cosmo Bio Company,Limited (2023 - 2019)

Historical Annual Revenue of Cosmo Bio Company,Limited (2023 - 2019)

Year Revenue Revenue Growth
2023 9.34 Billion JPY -2.23%
2022 9.55 Billion JPY 3.49%
2021 9.23 Billion JPY 14.08%
2020 8.09 Billion JPY 6.61%
2019 7.59 Billion JPY 0.0%

Peer Revenue Comparison of Cosmo Bio Company,Limited

Name Revenue Revenue Difference
Shin Nippon Biomedical Laboratories, Ltd. 26.45 Billion JPY 64.689%
DNA Chip Research Inc. 490.46 Million JPY -1804.327%
H.U. Group Holdings, Inc. 236.95 Billion JPY 96.058%
FALCO HOLDINGS Co., Ltd. 43 Billion JPY 78.283%
BML, Inc. 137.96 Billion JPY 93.23%
Human Metabolome Technologies, Inc. 1.34 Billion JPY -594.078%
Precision System Science Co., Ltd. 3.97 Billion JPY -134.676%